July 25, 2006

Mississippi sues pharmaceutical company

Mississippi has filed a legal action against Eli Lilly and Co. alleging a plan to defraud the state of millions of dollars in Medicaid reimbursements.

The lawsuit involves the "off-label" uses of the anti-psychotic drug Zyprexa, the Jackson (Miss.) Clarion Ledger reported.

The suit alleges representatives of Eli Lilly persuaded Mississippi doctors to prescribe the drug to patients suffering from conditions such as anxiety, mood swings and disturbed sleep when the drug is only approved to treat bipolar disorder and schizophrenia.

Tim Balducci, Mississippi special assistant attorney general, told the Clarion Ledger Eli Lilly targeted Mississippi because the state's Medicaid system cannot determine when a medication is prescribed for non-approved uses.

The Indianapolis-based Eli Lilly has 30 days to respond to the suit.

Citation: Mississippi sues pharmaceutical company (2006, July 25) retrieved 18 April 2024 from https://medicalxpress.com/news/2006-07-mississippi-sues-pharmaceutical-company_1.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Maternal mortality rate is much higher for Black women than white women in Mississippi, study says

Feedback to editors

Researchers discover new therapeutic target for non-small cell lung cancer

2 hours ago

Immune cells carry a long-lasting 'memory' of early-life pain

3 hours ago

Cannabis legalization and rising sales have not contributed to increase in substance abuse, study finds

3 hours ago

No negative impact from prolonged eye patching on child's development or family stress levels

3 hours ago

COVID-19 booster immunity lasts much longer than primary series alone, study shows

4 hours ago

Study finds that human neuron signals flow in one direction

5 hours ago

A common pathway in the brain that enables addictive drugs to hijack natural reward processing identified

5 hours ago

Scientists identify airway cells that sense aspirated water and acid reflux

5 hours ago

Environment may influence metacognitive abilities more than genetics

5 hours ago

Contracting RSV before age two can cause long-term lung changes and impairment

6 hours ago

Load comments (0)

Mississippi sues pharmaceutical company

Researchers discover new therapeutic target for non-small cell lung cancer

Immune cells carry a long-lasting 'memory' of early-life pain

Cannabis legalization and rising sales have not contributed to increase in substance abuse, study finds

No negative impact from prolonged eye patching on child's development or family stress levels

COVID-19 booster immunity lasts much longer than primary series alone, study shows

Study finds that human neuron signals flow in one direction

A common pathway in the brain that enables addictive drugs to hijack natural reward processing identified

Scientists identify airway cells that sense aspirated water and acid reflux

Environment may influence metacognitive abilities more than genetics

Contracting RSV before age two can cause long-term lung changes and impairment

Maternal mortality rate is much higher for Black women than white women in Mississippi, study says

New weight-loss drug Zepbound is now available, company says

African company to start making vaginal rings that protect against HIV

A Miami company recalls erectile dysfunction capsules: They might or might not work

Lawsuit accuses insurance company of using faulty AI to deny Medicare patient claims

Pharmaceutical compound sounds the alarm on cancer cells and unleashes T cells

Immune cells carry a long-lasting 'memory' of early-life pain

Study finds that human neuron signals flow in one direction

Researchers discover new therapeutic target for non-small cell lung cancer

A common pathway in the brain that enables addictive drugs to hijack natural reward processing identified

Scientists identify airway cells that sense aspirated water and acid reflux

Environment may influence metacognitive abilities more than genetics

Phys.org

Tech Xplore

Science X

Mississippi sues pharmaceutical company

Researchers discover new therapeutic target for non-small cell lung cancer

Immune cells carry a long-lasting 'memory' of early-life pain

Cannabis legalization and rising sales have not contributed to increase in substance abuse, study finds

No negative impact from prolonged eye patching on child's development or family stress levels

COVID-19 booster immunity lasts much longer than primary series alone, study shows

Study finds that human neuron signals flow in one direction

A common pathway in the brain that enables addictive drugs to hijack natural reward processing identified

Scientists identify airway cells that sense aspirated water and acid reflux

Environment may influence metacognitive abilities more than genetics

Contracting RSV before age two can cause long-term lung changes and impairment

Related Stories

Maternal mortality rate is much higher for Black women than white women in Mississippi, study says

New weight-loss drug Zepbound is now available, company says

African company to start making vaginal rings that protect against HIV

A Miami company recalls erectile dysfunction capsules: They might or might not work

Lawsuit accuses insurance company of using faulty AI to deny Medicare patient claims

Pharmaceutical compound sounds the alarm on cancer cells and unleashes T cells

Recommended for you

Immune cells carry a long-lasting 'memory' of early-life pain

Study finds that human neuron signals flow in one direction

Researchers discover new therapeutic target for non-small cell lung cancer

A common pathway in the brain that enables addictive drugs to hijack natural reward processing identified

Scientists identify airway cells that sense aspirated water and acid reflux

Environment may influence metacognitive abilities more than genetics

Newsletter sign up

Donate and enjoy an ad-free experience